GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (HKSE:03759) » Definitions » E10

Pharmaron Beijing Co (HKSE:03759) E10 : HK$0.31 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharmaron Beijing Co's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was HK$1.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.31 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Pharmaron Beijing Co's average E10 Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-03), Pharmaron Beijing Co's current stock price is HK$ 15.78. Pharmaron Beijing Co's E10 for the fiscal year that ended in Dec. 2024 was HK$0.31. Pharmaron Beijing Co's Shiller PE Ratio of today is 50.90.

During the past 11 years, the highest Shiller PE Ratio of Pharmaron Beijing Co was 52.60. The lowest was 37.62. And the median was 44.63.


Pharmaron Beijing Co E10 Historical Data

The historical data trend for Pharmaron Beijing Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co E10 Chart

Pharmaron Beijing Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.28 0.31

Pharmaron Beijing Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 - - - 0.31

Competitive Comparison of Pharmaron Beijing Co's E10

For the Biotechnology subindustry, Pharmaron Beijing Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaron Beijing Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Shiller PE Ratio falls into.


;
;

Pharmaron Beijing Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharmaron Beijing Co's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.08/118.9447*118.9447
=1.080

Current CPI (Dec. 2024) = 118.9447.

Pharmaron Beijing Co Annual Data

per_share_eps CPI Adj_EPS
201512 0.301 102.015 0.351
201612 0.174 103.225 0.200
201712 0.205 104.984 0.232
201812 0.285 107.622 0.315
201912 0.410 110.700 0.441
202012 0.779 109.711 0.845
202112 1.118 112.349 1.184
202212 0.864 114.548 0.897
202312 0.986 117.296 1.000
202412 1.080 118.945 1.080

Add all the adjusted EPS together and divide 10 will get our e10.


Pharmaron Beijing Co  (HKSE:03759) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pharmaron Beijing Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=15.78/0.31
=50.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of Pharmaron Beijing Co was 52.60. The lowest was 37.62. And the median was 44.63.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pharmaron Beijing Co E10 Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaron Beijing Co Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Gic Private Limited 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Matthews International Capital Management, Llc 2102 Investment manager
First H Share Award And Scheme Of Pharmaron Beijing Co., Ltd. 2301 Trustee
Kastle Limited 2301 Trustee
Jian Xin Bei Jing Tou Zi Ji Jin Guan Li You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Jian Xin Xin Tuo You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you

Pharmaron Beijing Co Headlines

No Headlines